Abstract
A 62-year-old man presented to our hospital with worsening respiratory distress. He had a history of uncontrolled diabetes mellitus and dyslipidemia and had received two doses of the COVID-19 adenovirus-vectored vaccine (ChAdOx1 nCoV-19) 4 months before presentation. Symptoms began 13 days before admission with headache, low-grade fever, and malaise. He had tested positive for COVID-19 and started treatment at home with supplementary oxygen and supportive measures. At day 13, he presented with worsening dyspnea and increasing oxygen requirements and was referred to our unit.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
